Hester Biosciences quarterly results and financials

Hester Biosciences (HESTERBIO)₹2,309−2.39%(9 Nov 2026 close)Pharmaceuticals

Key facts

In the Jun 2026 quarter (consolidated), Hester Biosciences reported sales of ₹76.69 Cr, down 8.5% from Jun 2025, and net profit of ₹97.01 Cr, up 471.0% year on year. For the year to Mar 2026, sales were ₹332 Cr and net profit ₹56.99 Cr.

Sales (Jun 2026): ₹76.69 Cr
Net profit (Jun 2026): ₹97.01 Cr
Sales (FY Mar 2026): ₹332 Cr
Net profit (FY Mar 2026): ₹56.99 Cr
EPS (Jun 2026): ₹114.13
Borrowings (Mar 2026): ₹195 Cr

Company filings, consolidated accounts; latest reported quarter Jun 2026

Hester Biosciences quarterly results

₹ crore unless stated; each column is a quarter.

Hester Biosciences Quarterly results
	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	69.81	66.73	78.69	81.72	83.66	62.81	81.79	83.78	70.81	76.77	99.67	76.69
Expenses	56.82	56.84	62.89	64.85	64.89	57.81	62.81	60.84	58.87	59.83	65.81	53.88
Operating Profit	12.99	10.01	15.99	18.01	19.01	4.99	18.99	23.01	12.01	17.99	34.01	23.01
OPM %	19.0%	15.0%	20.0%	20.9%	23.0%	8.0%	23.0%	26.9%	16.9%	23.0%	34.0%	29.0%
Other Income	6.02	2.01	5.02	2.01	3.01	9.04	−6.03	3.01	12.05	2.01	2.01	89.39
Interest	7.98	1.99	6.98	4.99	5.98	−3.99	5.98	1.99	1.99	1.99	4.99	2.99
Depreciation	3.99	4.01	3.99	3.99	3.99	3.99	3.99	3.99	3.99	3.99	5.99	6.99
Profit before tax	6.97	5.98	9.96	10.97	11.95	12.96	3.98	19.93	16.94	13.94	24.93	102
Tax %	40.0%	37.0%	35.0%	29.0%	29.0%	15.0%	59.0%	14.0%	16.0%	31.0%	34.0%	5.0%
Exceptional items	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.99	80.87
Net Profit	3.99	3.99	5.99	6.99	7.99	10.99	2.01	16.99	13.99	8.99	16.99	97.01
EPS (Rs)	4.82	4.69	5.83	7.46	9.65	13.72	1.53	19.35	17.00	10.32	18.79	114.13

Hester Biosciences profit and loss

₹ crore unless stated; years end in March. TTM is the last four quarters.

Hester Biosciences Profit and loss
	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	101	123	136	177	182	213	234	265	304	310	332	324
Expenses	66.88	81.74	88.76	110	128	146	175	214	251	249	245	238
Operating Profit	34.01	40.97	47.03	68.02	55.04	69.05	60.03	50.99	53.98	61.99	87.02	87.02
OPM %	33.9%	33.0%	35.0%	37.9%	30.0%	32.0%	26.0%	19.0%	18.0%	20.0%	26.0%	26.9%
Other Income	1.01	0.00	3.01	7.02	6.02	1.01	14.06	20.08	15.06	8.04	19.06	105
Interest	3.99	3.99	3.99	6.98	6.98	6.98	3.99	8.98	19.96	12.96	10.98	11.96
Depreciation	5.99	6.99	9.99	11.99	12.99	12.98	16.98	20.99	16.99	16.99	18.99	20.96
Profit before tax	24.91	30.90	35.88	56.79	40.86	49.78	53.77	39.82	31.88	39.83	75.78	158
Tax %	23.0%	26.0%	36.0%	28.0%	25.0%	31.0%	26.0%	30.0%	34.0%	27.0%	24.0%	—
Exceptional items	0.00	0.00	0.00	0.00	0.00	−1.99	0.00	0.00	0.00	0.00	1.99	82.86
Net Profit	18.99	22.97	22.98	40.95	30.99	34.98	38.97	27.99	20.98	29.01	56.99	137
EPS (Rs)	22.60	27.71	30.11	48.92	34.30	40.50	46.24	31.33	22.22	32.34	65.44	160.24
Dividend payout %	18.0%	19.0%	33.0%	23.0%	19.1%	25.1%	22.0%	26.0%	27.1%	22.0%	17.0%	—

Hester Biosciences balance sheet

₹ crore, at each year end.

Hester Biosciences Balance sheet
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	9.02	9.02	9.01	9.02	9.03	9.02	8.99	9.02	9.01	9.01	9.01	9.02
Reserves	76.06	93.00	113	132	169	193	220	251	271	283	306	352
Borrowings	55.13	59.11	66.19	69.17	90.30	121	105	228	274	244	213	195
Other Liabilities	20.09	25.12	25.12	35.16	32.15	65.31	78.38	74.36	117	127	127	124
Total Liabilities	160	186	213	245	300	388	412	563	671	663	653	679
Fixed Assets	60.24	65.21	102	110	146	144	133	238	260	241	234	412
CWIP	32.89	35.83	20.92	31.90	6.98	73.75	109	81.70	148	170	182	8.97
Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	20.93	24.91	29.89	33.87	42.89
Other Assets	68.17	85.21	89.17	102	148	170	169	223	237	222	203	215
Inventories	29.09	34.08	33.10	40.11	51.17	64.14	62.20	75.15	85.24	76.16	70.22	73.19
Trade receivables	17.99	25.98	26.99	31.99	33.03	58.01	48.99	54.98	80.01	78.95	72.97	94.95
Cash & equivalents	6.97	4.98	10.96	12.95	40.84	23.91	20.93	24.92	14.95	14.95	6.97	6.98
Total Assets	160	186	213	245	300	388	412	563	671	663	653	679

Hester Biosciences cash flow

₹ crore, for each year.

Hester Biosciences Cash flow
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from operating activity	20.01	19.01	35.01	37.98	46.97	37.02	57.99	9.01	23.99	47.96	64.95	63.98
Cash from investing activity	−21.05	−13.03	−30.08	−26.06	−21.05	−73.10	−42.09	−117	−77.13	−22.05	−20.04	−18.04
Cash from financing activity	7.03	−7.02	2.01	−11.04	3.01	19.07	−18.07	112	42.16	−26.08	−52.19	−49.18
Net cash flow	4.99	−0.99	5.99	0.99	27.93	−16.96	−1.99	2.99	−11.98	0.00	−6.98	−2.99
Capex	19.35	13.85	30.14	22.92	22.60	73.33	40.62	95.47	77.56	24.34	20.54	17.79
Free cash flow	0.99	4.99	4.99	14.96	23.94	−35.92	16.94	−86.78	−53.83	23.92	43.88	46.84
CFO / OP %	100.0%	74.0%	102.0%	100.0%	92.0%	86.0%	105.0%	43.0%	63.0%	112.0%	123.0%	90.0%

Hester Biosciences ratios

Working-capital days and returns, by year.

Hester Biosciences Ratios
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor days	71	94	78	86	66	115	83	85	108	93	85	104
Inventory days	431	627	376	505	540	834	452	424	399	288	291	323
Days payable	68	109	84	100	93	261	204	101	141	98	122	110
Cash conversion cycle	434	614	371	491	514	690	332	409	367	284	255	318
Working capital days	77	113	91	83	107	105	135	114	89	113	75	55
ROCE %	15.0%	19.0%	19.0%	20.0%	26.0%	16.0%	18.0%	14.0%	9.0%	9.0%	10.0%	15.0%

Hester Biosciences: frequently asked questions

What are the latest quarterly results of Hester Biosciences?

For the Jun 2026 quarter, Hester Biosciences reported sales of ₹76.69 Cr, down 8.5% year on year and net profit of ₹97.01 Cr, up 471.0% year on year. The operating margin was 29.0%.

What is the annual revenue of Hester Biosciences?

Hester Biosciences' sales for the year to Mar 2026 were ₹332 Cr; over the last twelve months they were ₹324 Cr.

What is the net profit of Hester Biosciences?

Net profit for the year to Mar 2026 was ₹56.99 Cr, and ₹137 Cr over the last twelve months. Earnings per share over the same trailing period were ₹160.24.

How much debt does Hester Biosciences have?

Hester Biosciences reported borrowings of ₹195 Cr at Mar 2026, against cash and equivalents of ₹6.98 Cr.

What is the free cash flow of Hester Biosciences?

Cash from operations was ₹63.98 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹46.84 Cr.

Loading…